Archives
-
EdU Imaging Kits (488) for UCMSC Proliferation
2026-09-24
EdU Imaging Kits (488) can help distinguish active DNA synthesis from broader changes in cell state. Using preeclampsia-derived umbilical cord mesenchymal stem cells as a case study, this article explains what an EdU result can—and cannot—show.
-
NSP15 Inhibitor Screening: Thymopentin and Oleuropein
2026-09-23
The 2021 reference study used structure-based virtual screening and molecular dynamics simulations to identify thymopentin and oleuropein as leading predicted binders of SARS-CoV-2 NSP15. Its main contribution is a computational prioritization framework for a viral immune-evasion target, while its findings require biochemical, cellular, and in vivo validation before therapeutic conclusions can be drawn.
-
MDL 28170: A Causal Calpain Inhibition Framework
2026-09-22
MDL 28170 is a selective calpain inhibitor that enables causal testing of protease-driven neuronal injury. This article translates recent BDNF/TrkB findings into assay design, controls, and cross-model interpretation for neuroprotection research.
-
Nullscript: Reliable HDAC Assay Design
2026-09-22
A scenario-driven guide to using Nullscript (SKU C3606) in HDAC, viability, cytotoxicity, and cardiac ischemia/reperfusion workflows. It connects product specifications with practical controls, interpretation limits, and emerging placental nanoplastic research without overstating cross-domain evidence.
-
Diminazene Aceturate: Assay Design Guide
2026-09-21
Diminazene Aceturate is a versatile research reagent whose trypanocidal and ACE2-associated activities require careful assay separation. This guide presents a formulation-aware framework for interpreting parasite phenotypes, mitochondrial endpoints, and preclinical cardiovascular findings.
-
L. gasseri, NR1I3, and E-Cadherin in Colitis
2026-09-21
Qian and colleagues show that Lactobacillus gasseri ATCC33323 alleviates DSS-induced colitis in mice by preserving epithelial barrier function through an NR1I3–E-cadherin regulatory pathway. The study combines probiotic intervention, intestinal E-cadherin loss-of-function modeling, microbiota assessment, transcriptional analysis, and in vitro validation to move beyond descriptive probiotic effects toward a mechanistic explanation.
-
Cytoskeleton-Dependent Autophagy Under Compression
2026-09-20
The reference study shows that compression-induced autophagy in human cells depends strongly on cytoskeletal organization, with microfilaments acting as the principal structural component and microtubules providing auxiliary support. Its perturbation-based design connects cellular mechanics with autophagosome responses and offers a useful framework for studying force-sensitive signaling without assuming that all cytoskeletal elements contribute equally.
-
Barley Leaf Senescence and Cathepsin Protease Activity
2026-09-19
Schepetkin and Fischer combine developmental sampling, fluorogenic protease assays, inhibitor profiling, activity-based labeling, and immunoblotting to characterize proteolysis during barley leaf senescence. Their results associate senescence with increased cathepsin B- and L-like activity, Rubisco loss, and induction of senescence-associated proteases, while also showing why inhibitor selectivity must be interpreted in complex plant extracts.
-
Separating Growth Arrest from Cell Death in Cancer Assays
2026-09-19
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly conflated measurements capture different components of an anticancer response. The framework supports more informative in vitro studies by combining response magnitude with timing and by separating proliferation arrest from genuine cell killing.
-
Nitrocefin Workflows for β-Lactamase Research
2026-09-18
Nitrocefin converts β-lactamase activity into a rapid yellow-to-red signal for visual screening, microplate kinetics, and inhibitor evaluation. This practical guide shows how to control solvent, timing, controls, and assay interpretation when profiling resistant organisms or recombinant enzymes.
-
Nitrocefin: Reliable β-Lactamase Assay Design
2026-09-17
This scenario-driven guide explains how Nitrocefin (SKU B6052) supports reproducible colorimetric β-lactamase assays, resistance profiling, and inhibitor screening. It also clarifies formulation, wavelength selection, controls, storage, and the limits of applying a β-lactamase substrate to cell viability workflows.
-
Cathepsin B inhibitor CA-074: Practical Protocol
2026-09-17
CA-074 (SKU A1926) is a selective cathepsin B inhibitor for testing protease-dependent activity in biochemical, cell-based, cancer metastasis, neurotoxicity, and immune-response workflows. Use it as a mechanistic research tool with vehicle, viability, and target-engagement controls; do not treat dossier observations as universal evidence across cell types or disease models.
-
Machine Learning for mRNA Vaccine LNP Design
2026-09-16
The reference study developed a LightGBM model to predict lipid nanoparticle formulations for mRNA vaccines from 325 formulation samples and reported strong predictive performance. By combining machine learning with animal validation and molecular dynamics, it showed how computational screening can prioritize ionizable lipids and formulation conditions while also revealing why experimental confirmation remains essential.
-
EdU Imaging Kits (488): Reliable Proliferation Data
2026-09-16
This scenario-driven guide explains how EdU Imaging Kits (488), SKU K1175, can improve S-phase DNA synthesis measurement when metabolic assays or BrdU workflows produce ambiguous results. It covers assay selection, compatibility, optimization, data interpretation, and practical vendor evaluation for cell proliferation and bioprocessing studies.
-
HyperScribe All in One mRNA Synthesis Kit Workflow
2026-09-15
Build capped, polyadenylated mRNA for translation, RNAi, antisense studies, and vaccine research with one integrated T7 transcription workflow. This guide connects practical reaction setup and troubleshooting with the spleen-targeted neoantigen vaccine strategy reported in hepatocellular carcinoma.